FMP
InVivo Therapeutics Holdings Corporation
NVIV
NASDAQ
Inactive Equity
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
0.321 USD
-0.1673 (-52.17%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Richard M. Toselli M.D.
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
CIK
0001292519
ISIN
US46186M6057
CUSIP
46186M605
Address
One Kendall Square
Phone
617 863 5500
Country
US
Employee
6
IPO Date
Nov 15, 2010
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
NVIV Financial Summary
CIK
0001292519
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
46186M605
ISIN
US46186M6057
Country
US
Price
0.32
Beta
0.66
Volume Avg.
3.77M
Market Cap
995.92k
Shares
-
52-Week
0.22-2.4
DCF
16.46
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.1
P/B
-
Website
https://www.invivotherapeutics.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NVIV News
It looks like there's no news available.
